CLINICAL_TRIALS
trial_result
· 2024-05-30
Clinical Trial Update: Intravitreal Bevacizumab for Age-Related Macular Degeneration [Phase 2]
Summary
Phase 2 trial evaluating intravitreal bevacizumab for age-related macular degeneration has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Age Related Macular Degeneration | Phase 2 | Status: TERMINATED